Autek China Inc

300595 · SHE · Healthcare / Medical Instruments & Supplies

10.23CNY+0.03 (+0.29%)

Price History

Full chart

Market Stats

Previous Close10.20

Open10.19

Day Range10.13 – 10.47

52-Week Range9.78 – 17.20

Volume12.42M

Market Cap9.09B

P/E (TTM)19.54

Forward P/E0.00

EPS0.52

Dividend Yield1.85%

Beta0.54

50-Day Avg10.89

200-Day Avg13.19

About

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices. Autek China Inc. was incorporated in 2000 and is based in Hefei, China.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOMr. Yuequn Tao
Employees3.75K
HeadquartersNo. 4899 Wangjiang West Road, Hefei, China, 230088, China
Websitehttps://www.orthok.cn

Leadership

Mr. Yuequn TaoGM & Chairman · b. 1960
Mr. Lizhi WeiCFO & Non-Independent Director · b. 1982
Ms. Xianmei ShiDeputy GM, Secretary, Operations Director & Non-Independent Director · b. 1974
Ms. Zhiying FuDeputy General Manager · b. 1983
Mr. Zhe ZhuDeputy General Manager · b. 1965
Mr. Yongzhan XiaoDeputy General Manager · b. 1970
Mr. Guoxin DongDeputy General Manager · b. 1968
Chang WangAccounting Supervisor

Financials

Income Statement

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	68.39M	91.01M	129.88M	176.24M	235.02M	311.63M	458.42M	646.90M	870.66M	1.30B	1.53B	1.74B	1.81B	1.85B
Growth (%)	-	+33.08%	+42.71%	+35.69%	+33.35%	+32.60%	+47.10%	+41.12%	+34.59%	+48.74%	+17.78%	+13.89%	+4.40%	+2.00%
Cost of Revenue	16.44M	18.56M	29.69M	40.60M	60.92M	74.13M	100.93M	139.67M	186.82M	301.93M	352.51M	440.10M	485.32M	639.62M
Gross Profit	51.94M	72.45M	100.19M	135.64M	174.10M	237.50M	357.49M	507.23M	683.84M	993.11M	1.17B	1.30B	1.33B	1.21B
Gross Margin	75.95%	79.61%	77.14%	76.96%	74.08%	76.21%	77.98%	78.41%	78.54%	76.69%	76.89%	74.67%	73.24%	65.42%
Operating Expense	18.46M	40.26M	27.53M	34.28M	42.63M	58.49M	112.20M	173.53M	209.88M	308.55M	374.30M	441.39M	589.01M	587.23M
Operating Income	33.48M	32.20M	72.65M	101.36M	131.47M	179.01M	245.29M	333.71M	473.96M	684.57M	798.51M	855.67M	739.28M	622.97M
Operating Margin	48.96%	35.38%	55.94%	57.51%	55.94%	57.44%	53.51%	51.59%	54.44%	52.86%	52.35%	49.26%	40.76%	33.68%
EBITDA	33.80M	30.34M	68.40M	97.58M	127.98M	169.60M	222.94M	305.40M	444.70M	634.37M	733.22M	784.57M	738.24M	622.97M
EBITDA Margin	49.43%	33.33%	52.67%	55.37%	54.45%	54.42%	48.63%	47.21%	51.08%	48.98%	48.07%	45.16%	40.71%	33.68%
Net Income	30.08M	24.80M	63.77M	88.70M	114.04M	150.86M	216.24M	306.89M	433.32M	554.74M	623.85M	666.60M	572.23M	479.52M
Net Income Margin	43.99%	27.25%	49.10%	50.33%	48.52%	48.41%	47.17%	47.44%	49.77%	42.84%	40.90%	38.37%	31.55%	25.92%
R&D	2.54M	3.47M	5.50M	6.12M	7.85M	10.40M	12.84M	16.08M	19.03M	27.34M	33.63M	40.30M	42.28M	43.87M
R&D as % of Total Revenue	3.71%	3.81%	4.24%	3.48%	3.34%	3.34%	2.80%	2.49%	2.19%	2.11%	2.20%	2.32%	2.33%	2.37%
Interest Expense	-	65.66K	92.56K	92.14K	147.69K	192.47K	447.39K	1.05M	1.37M	8.64M	10.43M	12.14M	15.55M	16.70M
Interest Expense % of Total Revenue	-	0.07%	0.07%	0.05%	0.06%	0.06%	0.10%	0.16%	0.16%	0.67%	0.68%	0.70%	0.86%	0.90%

Balance Sheet

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	116.13M	162.92M	210.19M	296.80M	357.50M	922.57M	1.23B	1.61B	2.21B	2.97B	5.12B	5.52B	6.03B	6.30B
Total Liabilities	10.88M	17.06M	18.11M	43.27M	41.56M	110.23M	145.28M	168.17M	221.74M	436.35M	523.05M	807.85M	887.24M	849.48M
Total Equity	105.24M	145.86M	190.66M	252.43M	311.49M	804.98M	1.02B	1.33B	1.75B	2.22B	4.23B	4.35B	4.70B	4.91B
Cash	25.80M	89.44M	156.70M	218.25M	229.56M	165.59M	178.28M	218.15M	326.26M	655.69M	953.03M	1.06B	758.37M	847.85M
Total Debt	-	-	-	-	-	42.58M	48.65M	200.00K	1.00M	163.56M	225.35M	182.89M	202.38M	307.64M
Net Debt	-25.80M	-89.44M	-156.70M	-218.25M	-229.56M	-123.01M	-129.63M	-217.95M	-325.26M	-492.13M	-727.68M	-712.39M	-555.99M	-540.21M

Cash Flow

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	19.18M	53.37M	61.91M	80.23M	108.80M	144.71M	148.52M	275.37M	380.94M	630.09M	651.72M	723.38M	684.91M	827.38M
Investing Cash Flow	-63.19M	13.77M	22.05M	-10.43M	-27.10M	-592.32M	-140.21M	-237.60M	-282.49M	-101.39M	-1.66B	-602.66M	-693.66M	-76.40M
Financing Cash Flow	51.00M	-3.55M	-16.71M	-8.11M	-70.32M	383.64M	4.38M	2.11M	9.67M	-199.72M	1.30B	-618.43M	-290.48M	-665.04M
Capital Expenditure	3.81M	5.02M	2.57M	15.47M	28.60M	62.80M	35.25M	57.11M	94.42M	137.81M	129.39M	197.93M	206.57M	120.71M
Free Cash Flow	15.37M	48.36M	59.34M	64.76M	80.20M	81.91M	113.27M	218.25M	286.52M	492.28M	522.33M	525.45M	478.33M	706.67M
Dividends Paid	10.00M	14.00M	18.97M	8.11M	73.67M	23.80M	25.06M	31.41M	40.46M	124.53M	124.38M	125.23M	203.35M	250.87M
FCF to OCF	80.12%	90.60%	95.85%	80.72%	73.71%	56.61%	76.27%	79.26%	75.21%	78.13%	80.15%	72.64%	69.84%	85.41%
Dividend Paid to FCF	65.07%	28.95%	31.97%	12.53%	91.85%	29.05%	22.12%	14.39%	14.12%	25.30%	23.81%	23.83%	42.51%	35.50%

Earnings

Report Date	Apr 26, 2017	Aug 28, 2017	Oct 29, 2017	Feb 27, 2018	Apr 26, 2018	Aug 22, 2018	Oct 26, 2018	Feb 25, 2019	Apr 24, 2019	Aug 27, 2019	Oct 25, 2019	Feb 25, 2020	Apr 24, 2020	Aug 26, 2020	Oct 26, 2020	Mar 29, 2021	Apr 26, 2021	Aug 4, 2021	Oct 25, 2021	Mar 28, 2022	Apr 26, 2022	Aug 5, 2022	Oct 21, 2022	Mar 31, 2023	Apr 24, 2023	Aug 10, 2023	Oct 23, 2023	Jan 25, 2024	Apr 26, 2024	Aug 15, 2024	Oct 25, 2024	Mar 28, 2025	Apr 25, 2025	Aug 22, 2025	Oct 24, 2025	Mar 27, 2026	Apr 23, 2026	Aug 28, 2026
EPS Estimate	-	-	-	-	-	-	0.11	0.06	-	0.15	0.18	0.16	-	-	-	0.16	-	-	-	0.14	0.16	0.12	0.25	0.16	0.18	0.20	0.29	0.13	0.21	0.15	0.21	0.11	0.23	0.13	0.23	0.10	-	0.12
EPS Actual	0.02	0.04	0.07	0.05	0.09	0.08	0.14	0.08	0.09	0.08	0.13	0.09	0.04	0.11	0.17	0.18	0.23	0.14	0.22	0.13	0.16	0.12	0.29	0.12	0.19	0.15	0.23	0.14	0.19	0.15	0.21	0.06	0.16	0.08	0.20	0.02	0.16	0.08
Surprise	-	-	-	-	-	-	27.27%	33.33%	-	-46.67%	-27.78%	-43.75%	-	-	-	12.50%	-	-	-	-7.14%	0.00%	0.00%	16.00%	-25.00%	5.56%	-25.00%	-20.69%	7.69%	-9.52%	0.00%	0.00%	-45.45%	-30.43%	-38.46%	-13.04%	-80.00%	-	-33.33%
Timing	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	After-hours	After-hours	Pre-market	Pre-market	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	After-hours

Key Statistics & Ratios

Market Cap9.09B

Enterprise Value7.21B

Trailing P/E19.54

Forward P/E0.00

Price / Sales4.90

Price / Book1.83

EPS0.52

Book Value5.62

Revenue (TTM)1.86B

Gross Profit (TTM)1.31B

EBITDA658.92M

Profit Margin24.87%

Operating Margin26.83%

Return on Equity9.78%

Return on Assets6.14%

Shares Outstanding894.36M

Shares Float467.13M

Beta0.54

Dividend Yield1.85%

Dividend Rate0.19

Payout Ratio40.58%

Dividends

20262×

0.05Oct 20, 20260.13May 20, 2026

20252×

0.06Nov 5, 20250.22May 15, 2025

20241×

0.22May 16, 2024

20231×

0.14May 16, 2023

20221×

0.15May 6, 2022

20211×

0.20May 21, 2021

20201×

0.07May 20, 2020

20191×

0.07May 17, 2019

20181×

0.06May 25, 2018

20171×

0.05May 23, 2017

Stock Splits

May 21, 20217:5
May 20, 20203:2
May 17, 2019195077:108376
May 25, 2018195077:108376
May 23, 2017195077:108376